Evidence map›Paper›PMID 36252717›Full record

ArticleThe American journal of medicine2023

Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN].

Dina Halegoua-DeMarzio, Victor Navarro, Jawad Ahmad, Bharathi Avula, Huiman Barnhart, A Sidney Barritt, Herbert L Bonkovsky, Robert J Fontana, Marwan S Ghabril, Jay H Hoofnagle and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Curcumin enhances the oral bioavailability of testosterone by inhibiting its intestinal metabolism.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Trial
  3. Review
  4. Article
  5. Article
  6. [Research advances on the role of eosinophils in acute liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Common Causes of Drug-Induced Liver Injury in 2025.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 13 institutions in 1 country.

Dina Halegoua-DeMarzioThomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia, Pa. Electronic address: dlh004@jefferson.edu.
Victor NavarroAlbert Einstein Medical Center, Philadelphia, Pa.
Jawad AhmadIcahn School of Medicine at Mount Sinai, New York, NY.
Bharathi AvulaUniversity of Mississippi, University Park.
Huiman BarnhartDuke Clinical Research Institute, Durham, NC.
A Sidney BarrittUniversity of North Carolina, Chapel Hill.
Herbert L BonkovskyWake Forest University School of Medicine, Winston-Salem, NC.
Robert J FontanaUniversity of Michigan Medical School, Ann Arbor.
Marwan S GhabrilIndiana University School of Medicine, Indianapolis.
Jay H HoofnagleNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.
Ikhlas A KhanUniversity of Mississippi, University Park.
David E KleinerNational Cancer Institute, National Institutes of Health, Bethesda, Md.
Elizabeth PhillipsVanderbilt University Medical Center, Nashville, Tenn.
Andrew StolzUniversity of Southern California Keck School of Medicine, Los Angeles, Calif.
Raj VuppalanchiIndiana University School of Medicine, Indianapolis.
Indiana University School of MedicineUniversity of Mississippi · USClinical Research Institute · USEinstein Medical Center Philadelphia · USIcahn School of Medicine at Mount Sinai · USNational Institute of Diabetes and Digestive and Kidney Diseases · USNational Institutes of Health · USThomas Jefferson University · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · USVanderbilt University Medical Center · USWake Forest University · US

Funding

Drug Induced Liver Injury Network Data Coordinating CenterU01DK065176 · NIDDK · DUKE UNIVERSITY · PI Huiman X Barnhart · 2003 to 2026
$25.5M
Postmortem PathologyZICBC010685 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLEINER, DAVID ERWIN · 2009 to 2025
$14.3M
Coordinating Center for the Drug Induced Liver Injury Network (DILIN)U24DK065176 · NIDDK · DUKE UNIVERSITY · PI BARNHART, HUIMAN X · 2018 to 2022
$7.6M
IU Clinical Center: Drug Induced Liver Injury NetworkU01DK065211 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI NAGA P CHALASANI · 2003 to 2026
$7.5M
University of North Carolina Clinical Center for DILINU01DK065201 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAUL B WATKINS · 2003 to 2026
$7.3M
Michigan Hepatotoxicity Clinical Research Network Renewal 2018U01DK065184 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROBERT J FONTANA · 2003 to 2026
$7.0M
The Drug Induced Liver Injury Network (DILIN): Focus on Herbal and DietarySupplementsU01DK083027 · NIDDK · THOMAS JEFFERSON UNIVERSITY · PI Dina Halegoua-DeMarzio · 2008 to 2026
$7.0M
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.U01DK083020 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Lily Dara · 2008 to 2026
$5.9M
Mount Sinai Regional Drug Induced Liver Injury Network SiteU01DK100928 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI AHMAD, JAWAD, ODIN, JOSEPH · 2013 to 2022
$4.0M
Hepatotoxicity Clinical Research NetworkU01DK065238 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAVERN, TIMOTHY JAMES · 2003 to 2012
$1.9M
UT Southwestern: Clinical Site for the Drug-Induced Liver Injury NetworkU01DK083023 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI LEE, WILLIAM M · 2008 to 2012
$1.3M
Research Network for Drug-Induced Liver DiseaseU01DK065193 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PROTIVA, PETR · 2003 to 2007
$1.2M
NIDDK NIH HHS U01 DK065176NIDDK NIH HHS U01 DK065184NIDDK NIH HHS U01 DK065193NIDDK NIH HHS U01 DK065201NIDDK NIH HHS U01 DK065211NIDDK NIH HHS U01 DK065238NIDDK NIH HHS U01 DK082992NIDDK NIH HHS U01 DK083020NIDDK NIH HHS U01 DK083023NIDDK NIH HHS U01 DK083027NIDDK NIH HHS U01 DK100928NIDDK NIH HHS U24 DK065176
6 · The paper itself

Abstract

backgroundTurmeric is a commonly used herbal product that has been implicated in causing liver injury. The aim of this case series is to describe the clinical, histologic, and human leukocyte antigen (HLA) associations of turmeric-associated liver injury cases enrolled the in US Drug-Induced Liver Injury Network (DILIN).

methodsAll adjudicated cases enrolled in DILIN between 2004 and 2022 in which turmeric was an implicated product were reviewed. Causality was assessed using a 5-point expert opinion score. Available products were analyzed for the presence of turmeric using ultra-high-performance liquid chromatography. Genetic analyses included HLA sequencing.

resultsTen cases of turmeric-associated liver injury were found, all enrolled since 2011, and 6 since 2017. Of the 10 cases, 8 were women, 9 were White, and median age was 56 years (range 35-71). Liver injury was hepatocellular in 9 patients and mixed in 1. Liver biopsies in 4 patients showed acute hepatitis or mixed cholestatic-hepatic injury with eosinophils. Five patients were hospitalized, and 1 patient died of acute liver failure. Chemical analysis confirmed the presence of turmeric in all 7 products tested; 3 also contained piperine (black pepper). HLA typing demonstrated that 7 patients carried HLA-B*35:01, 2 of whom were homozygous, yielding an allele frequency of 0.450 compared with population controls of 0.056-0.069.

conclusionLiver injury due to turmeric appears to be increasing in the United States, perhaps reflecting usage patterns or increased combination with black pepper. Turmeric causes potentially severe liver injury that is typically hepatocellular, with a latency of 1 to 4 months and strong linkage to HLA-B*35:01.

Indexed as

Chemical and Drug Induced Liver InjuryHepatitisAdultAgedCurcumaDyphyllineFemaleHumansMaleMiddle AgedUnited StatesDyphyllineDrug-induced liver injuryHepatotoxicityHerbal-induced liver injuryTurmeric

Identifiers

PMID36252717
PMCPMC9892270
OpenAlexW4306168950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.